Management Team
BOD
SAB
CAB
About Metabolic Diseases
Home
>
About
>
Board of Directors
>
Investors
Metabolex is privately held. We are supported by investors who have invested an aggregate of $117 million since August 2003. Our major investors include:
Alta Partners
KBC Funds
Alliance Bernstein
MPM BioEquities
Bay City Capital
Merlin Biomed Group
Birchmere Ventures
Novo Ventures
Biotech Turnaround Fund BV
Pictet Funds (LUX)
Charter Life Sciences
T. Rowe Price
Deerfield Management
VantagePoint Ventures
Johnson & Johnson Development Corporation
Venrock Partners
Lombard Odier Darier Hentsch
Versant Ventures
